Discovery of novel 2-(alkylmorpholin-4-yl)-6-(3-fluoropyridin-4-yl)-pyrimidin-4(3H)-ones as orally-active GSK-3β inhibitors for Alzheimer’s disease

Kenji Fukunaga, Daiki Sakai, Kazutoshi Watanabe, Kazuki Nakayama, Toshiyuki Kohara, Hiroshi Tanaka, Shinji Sunada, Mika Nabeno, Masako Okamoto, Junichi Eguchi,

Bioorganic & Medicinal Chemistry Letters · 2015 · 31 citations · 6 references

DOIFull text

Open access

Concepts

References

6